ANI PHARMACEUTICALS, INC Stock or Unit Option Plan Expense
ANI PHARMACEUTICALS, INC (ANIP) reported Stock or Unit Option Plan Expense of $900.00 thousand for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-03.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:StockOptionPlanExpense · last filed 2015-11-03
- ANI PHARMACEUTICALS, INC stock or unit option plan expense for the quarter ending 2015-09-30 was $900.00K, a 50.00% increase year-over-year.
- ANI PHARMACEUTICALS, INC stock or unit option plan expense for the quarter ending 2015-06-30 was $800.00K, a 57.89% decline year-over-year.
- ANI PHARMACEUTICALS, INC stock or unit option plan expense for the quarter ending 2015-03-31 was $500.00K, a 12400.00% increase year-over-year.
- ANI PHARMACEUTICALS, INC stock or unit option plan expense for the quarter ending 2014-09-30 was $600.00K, a 19900.00% increase year-over-year.
| Period end | Stock or Unit Option Plan Expense 3 month | Stock or Unit Option Plan Expense 6 month | Stock or Unit Option Plan Expense 9 month |
|---|---|---|---|
| 2015-09-30 | $900.00K 10-Q · filed 2015-11-03 | $1.70M derived: sum of 2 quarters · filed 2015-11-03 | $2.10M 10-Q · filed 2015-11-03 |
| 2015-06-30 | $800.00K 10-Q · filed 2015-08-04 | $1.30M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $500.00K 10-Q · filed 2015-05-05 | ||
| 2014-09-30 | $600.00K 10-Q · filed 2015-11-03 | $2.50M derived: sum of 2 quarters · filed 2015-11-03 | $2.50M 10-Q · filed 2015-11-03 |
| 2014-06-30 | $1.90M 10-Q · filed 2015-08-04 | $1.90M 10-Q · filed 2015-08-04 | |
| 2014-03-31 | $4.00K 10-Q · filed 2015-05-05 | ||
| 2013-09-30 | $3.00K 10-Q · filed 2014-11-10 | $3.00K 10-Q · filed 2014-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |